Intesa Sanpaolo SpA.’s Moderna MRNA Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Hold	2,434	–	–	0.01%	186
2026 Q1	$124K	Buy	2,434 +750	+45%	+$35K	0.01%	179
2025 Q4	$51.2K	Buy	+1,684	New	+$45.8K	﹤0.01%	191

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Intesa Sanpaolo SpA.'s MRNA Position: Q2 2026 in Review

Intesa Sanpaolo SpA. held its Moderna (MRNA) position steady in Q2 2026 at 2,434 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #186.

Intesa Sanpaolo SpA. first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Intesa Sanpaolo SpA. held 2,434 shares of Moderna worth $170K as of Q2 2026.
Intesa Sanpaolo SpA. left its Moderna share count unchanged in Q2 2026.
Moderna made up 0.01% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #186 holding.
Intesa Sanpaolo SpA. first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.